Understand the source comparison
Cerebrolysin and Other Peptides: Compatibility Comparison
Growth Hormone Secretagogues GHRP-2, Ipamorelin, MK-677 Stimulates pulsatile GH release via ghrelin receptor agonism High. No pathway overlap Administer GH peptides morning or pre-workout; Cerebrolysin evening or alternate days Additive benefits for recovery a
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Growth Hormone Secretagogues
- GHRP-2, Ipamorelin, MK-677
- Stimulates pulsatile GH release via ghrelin receptor agonism
- High. No pathway overlap
- Administer GH peptides morning or pre-workout; Cerebrolysin evening or alternate days
- Additive benefits for recovery and neuroplasticity without receptor competition
- Tissue Repair Peptides
- BPC-157, TB-500
- Angiogenesis, collagen synthesis, systemic anti-inflammatory signalling
- High. Distinct mechanisms
- Separate by injection site; minimum 4-hour window if same anatomical region
- Clean stack. Repair pathways and neuroprotection work in parallel
- Nootropic Peptides
- Semax, Selank, Dihexa
- BDNF modulation (Semax), anxiolytic GABAergic effects (Selank), HGF upregulation (Dihexa)
- Moderate to High. Semax creates additive BDNF effects; Selank and Dihexa no overlap
- Intranasal peptides opposite time of day from IM Cerebrolysin
- Semax + Cerebrolysin shows additive cognitive benefit in research models; Selank reduces anxiety without interfering
- Metabolic Peptides
- MOTS-C, Humanin
- Mitochondrial biogenesis, metabolic signalling via mitochondrial-derived peptides
- High. No CNS receptor overlap
- Administer MOTS-C or Humanin separately by 6+ hours from Cerebrolysin
- Mitochondrial and neurotrophic pathways are complementary
- GLP-1 Agonists
- Semaglutide, Tirzepatide
- GLP-1 receptor agonism for metabolic regulation and appetite suppression
- High. No interaction
- No timing restriction required
- Completely separate mechanisms. Metabolic vs neuroprotective
- Other Neurotrophic Agents
- P21, NSI-189
- CREB pathway modulation (P21), hippocampal neurogenesis (NSI-189)
- Low to Moderate. Potential redundancy in BDNF/CREB signalling
- Use separately or cycle. Not simultaneously
- Functional overlap reduces marginal benefit of stacking